Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity

ACKNOWLEDGMENT Supported by the National Health and Medical Research Council of Australia, The Cancer Council of New South Wales, Cancer Institute New South Wales, Royal Australasian College of Surgeons, St Vincent’s Clinic Foundation, R.T. Hall Trust, and the Avner Nahmani Pancreatic Cancer Foundation (Australia); the Chief Scientist’s Office of the Scottish Government (UK); and the Italian Association for Cancer Research, Fondazione Cariverona, and Miriam Cherubini Loro (Italy).